List your company

BIGPRO®

Drug discovery and biotech · by AnHorn Medicines

Proprietary protein degrader developed by AnHorn Medicines using its generative AI platform.

Visit website

What it does

Proprietary protein degrader developed by AnHorn Medicines using its generative AI platform. BI-functional liGand induced PROteolysis molecules that selectively eliminate disease-driving proteins, with focus on prescription aesthetics and oncology.

  • Autonomous drug design and optimization
  • Design of small molecular inhibitors
  • Design of molecular target binders
  • Design of protein degrader drug molecules
Category
Drug discovery and biotech
Built for
Healthcare and life sciences
Users
Pharmaceutical and biotechnology researchers, Drug discovery ecosystem partners
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

AnHorn Medicines doesn't list prices publicly. Ask them for a quote.

Security and compliance

As reported by AnHorn Medicines. Ask for audit reports before you buy.

  • firewalls
  • anti-virus systems
  • access controls
  • confidentiality agreements for personnel

Reviews

No reviews yet

Reviews come from people who use BIGPRO® at work. Share how your team uses it to help other buyers decide.

Write a review

Alternatives

  • ITO™ Platform

    by 1910

    Cloud-based end-to-end platform integrating massive multimodal data, frontier AI models, and high-throughput lab automation to deliver small and large molecule drug candidates f...

  • AI Agents

    by Enjamb Labs

    Agentic orchestration that coordinates specialized agents across evidence, trial design, statistical programming, and regulatory writing inside one auditable workspace.

  • Integrations

    by Invert

    Pre-built connectivity to every instrument, historian, ELN/LIMS, and enterprise data store that matters in bioprocess.

  • Numerion Labs Drug Discovery Platform

    by Numerion Labs

    AI-driven drug-hunting superplatform that uses a universal chemistry foundation model (COSMOS), a hyper-scalable enumerator (APEX), and expert optimization algorithms (EXPO) to...

  • Quinn

    Scientific evidence synthesis service delivering structured evidence packages for target, indication, biomarker, and trial design decisions on named drug assets.

  • Precision medicine

    by Parallel Bio

    Maps of human biology for personalized insights and patient stratification in ways never previously possible.

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim BIGPRO®